Clinical Trial Update: Ticagrelor and Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial update for ticagrelor in peripheral arterial disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Arkansas Heart Hospital | Conditions: Peripheral Arterial Disease | Phase 4 | Status: TERMINATED